This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Millennium Pharmaceuticals Limited. Active years: 1999-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2000
Title: Andrew Dj Goodearl: Innovator in Nucleic Acid Molecules
Introduction
Andrew Dj Goodearl is an inventor based in Sherborn, MA (US). He has made significant contributions to the field of nucleic acid molecules. Although he currently holds no granted patents, his work is noteworthy for its potential applications in diagnostics and therapeutics.
Latest Patent Applications
Andrew Dj Goodearl has submitted several patent applications, including NOVEL 15571, 2465, 14266, 2882, 52871, 8203 AND 16852 MOLECULES AND USES THEREFOR. This invention provides isolated nucleic acid molecules, designated 15571, 2465, 14266, 2882, 52871, 8203, or 16852. The invention also includes antisense nucleic acid molecules, recombinant expression vectors containing these nucleic acid molecules, and host cells into which the expression vectors have been introduced. Furthermore, it encompasses nonhuman transgenic animals in which a 15571, 2465, 14266, 2882, 52871, 8203, or 16852 gene has been introduced or disrupted. The invention also provides isolated proteins, fusion proteins, antigenic peptides, and antibodies related to these nucleic acid molecules. Diagnostic and therapeutic methods utilizing the compositions of this invention are also included.
Conclusion
Andrew Dj Goodearl is an innovative inventor whose work in nucleic acid molecules holds promise for future advancements in medical science. His patent applications reflect a commitment to exploring the potential of these molecules in various applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile